These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32418509)

  • 21. Gonococcal antimicrobial resistance: the implications for public health control.
    Ndowa FJ; Ison CA; Lusti-Narasimhan M
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv1-2. PubMed ID: 24243872
    [No Abstract]   [Full Text] [Related]  

  • 22. Australian Gonococcal Surveillance Programme, 1 July to 30 September 2016
.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2017 Mar; 41(1):E109-E110. PubMed ID: 28385144
    [No Abstract]   [Full Text] [Related]  

  • 23. Australian Gonococcal Surveillance Programme 1 July to 30 September 2020.
    Lahra MM; Shoushtari M; Hogan TR
    Commun Dis Intell (2018); 2020 Nov; 44():. PubMed ID: 33349202
    [No Abstract]   [Full Text] [Related]  

  • 24. Australian Gonococcal Surveillance Programme annual report, 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2017 Mar; 41(1):E. PubMed ID: 28385139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial resistance monitoring in Neisseria gonorrhoeae and strategic use of funds from the Global Fund to set up a systematic Moroccan gonococcal antimicrobial surveillance programme.
    Hançali A; Ndowa F; Bellaji B; Bennani A; Kettani A; Charof R; El Aouad R
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv24-7. PubMed ID: 24037141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the Gonococcal Isolate Surveillance Project (GISP), January 2006-June 2012.
    Kirkcaldy RD; Kidd S; Weinstock HS; Papp JR; Bolan GA
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv5-10. PubMed ID: 24243881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Technological Solutions to Address Drug-Resistant Neisseria gonorrhoeae.
    Bristow CC; Dong H; Klausner JD
    Emerg Infect Dis; 2016 May; 22(5):939-40. PubMed ID: 27088665
    [No Abstract]   [Full Text] [Related]  

  • 28. Antimicrobial susceptibility in
    Latif AS; Gwanzura L; Machiha A; Ndowa F; Tarupiwa A; Gudza-Mugabe M; Shukusho FD; Chakanyuka Musanhu C; Wi T; Unemo M
    Sex Transm Infect; 2018 Feb; 94(1):62-66. PubMed ID: 28476914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.
    Jabeen K; Bhawan Mal P; Khan E; Chandio S; Jacobsson S; Unemo M
    BMC Infect Dis; 2016 Jul; 16():353. PubMed ID: 27449234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area.
    Cole MJ; Quinten C; Jacobsson S; Day M; Amato-Gauci AJ; Woodford N; Spiteri G; Unemo M;
    BMC Infect Dis; 2019 Dec; 19(1):1040. PubMed ID: 31822275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Australian Gonococcal Surveillance Programme annual report, 2012.
    Lahra MM;
    Commun Dis Intell Q Rep; 2013 Sep; 37(3):E233-9. PubMed ID: 24890959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2006.
    WHO Western Pacific Gonococccal Antimicrobial Surveillance Programme
    Commun Dis Intell Q Rep; 2008 Mar; 32(1):48-51. PubMed ID: 18524033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of antimicrobial resistance in Neisseria gonorrhoeae in an HIV/AIDS clinic.
    Chan DJ; Tapsall J
    Int J STD AIDS; 2006 Jun; 17(6):410-2. PubMed ID: 16734965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Annual report of the Australian Gonococcal Surveillance Programme, 2011.
    Lahra MM;
    Commun Dis Intell Q Rep; 2012 Jun; 36(2):E166-73. PubMed ID: 23186215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of Neisseria gonorrhoeae to Gentamicin-Gonococcal Isolate Surveillance Project, 2015-2016.
    Mann LM; Kirkcaldy RD; Papp JR; Torrone EA
    Sex Transm Dis; 2018 Feb; 45(2):96-98. PubMed ID: 29324629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial susceptibility and molecular epidemiology of Neisseria gonorrhoeae in Germany.
    Horn NN; Kresken M; Körber-Irrgang B; Göttig S; Wichelhaus C; Wichelhaus TA;
    Int J Med Microbiol; 2014 Jul; 304(5-6):586-91. PubMed ID: 24801146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Annual Report of the Australian Gonococcal Surveillance Programme, 2009.
    Australian Gonococcal Surveillance Programme
    Commun Dis Intell Q Rep; 2010 Jun; 34(2):89-95. PubMed ID: 20690208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Annual report of the Australian Gonococcal Surveillance Programme, 2008.
    ; Tapsall J
    Commun Dis Intell Q Rep; 2009 Sep; 33(3):268-74. PubMed ID: 20047199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospects of untreatable gonorrhea and ways forward.
    Whiley DM; Lahra MM; Unemo M
    Future Microbiol; 2015; 10(3):313-6. PubMed ID: 25812453
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece: data for the years 1994-2004.
    Stathi M; Flemetakis A; Miriagou V; Avgerinou H; Kyriakis KP; Maniatis AN; Tzelepi E
    J Antimicrob Chemother; 2006 Apr; 57(4):775-9. PubMed ID: 16492719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.